CAR, AbbVie, Merck, and Johnson & Johnson are developing cutting-edge therapies for DLBCL.

The entities involved

• CAR →
  • CAR partnered with the Hospital of the University of Pennsylvania to form Noventra Oncology Alliance, announcing the joint venture headquarters in Philadelphia.Mon 06:18
  • Atlanticus Holdings Corporation completed the sale of its entire Auto Finance segment.Thu 10:20
• AbbVie →

  pharmaceutical company

  • MarketBeat's screener has identified a list of dividend stocks.Sun 22:22
  • AbbVie's product portfolio was bolstered by the acquisition of Allergan, while Humira sales faced erosion due to patent loss and biosimilar competition.Sun 13:48
• Merck →

  public company in Indonesia

  • Eli Lilly, Novo Nordisk, and Merck are currently competing in the highly competitive GLP-1 obesity market.Sat 17:22
  • Merck will share clinical trial results at the American Academy of Ophthalmology (AAO) meeting.Fri 18:13
• Johnson & Johnson →

  U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer

  • P&G, Johnson & Johnson, and Coca-Cola are noted as dividend growth stocks, coinciding with SEC requirements for fiduciaries to prioritize interests.Mon 00:50
  • Johnson & Johnson separated its Consumer Health business into Kenvue on August 25, 2025.Sun 04:04